本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ABVC BioPharma, Inc.

1.06
+0.05775.77%
成交量:21.98萬
成交額:22.81萬
市值:2,819.23萬
市盈率:-3.71
高:1.08
開:1.00
低:1.00
收:1.00
52周最高:3.40
52周最低:0.7069
股本:2,665.44萬
流通股本:2,182.62萬
量比:3.24
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-0.2855
每股收益(LYR):-0.3933
淨資產收益率:-69.86%
總資產收益率:-22.85%
市淨率:2.74
市盈率(LYR):-2.69

資料載入中...

2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/15

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/10/08

重要事件披露

8-K - Current report
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/29

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/07/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/08

重要事件披露

8-K/A [Amend] - Current report
2021/05/14

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K/A [Amend] - Current report
2021/04/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/11

重要事件披露

8-K - Current report
2021/01/08

重要事件披露

8-K - Current report
2021/01/07

重要事件披露

8-K - Current report